Status:
WITHDRAWN
Clinical Outcomes of Patients With COVID19
Lead Sponsor:
Guangzhou Institute of Respiratory Disease
Collaborating Sponsors:
Huizhou Municipal Central Hospital
Conditions:
Coronavirus Disease 2019
Eligibility:
All Genders
Brief Summary
As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considere...
Eligibility Criteria
Inclusion
- Hospitalized patients with COVID19
Exclusion
- Suspected patients with COVID19, not confirmed by the laboratory
- Patients who are refused to receive medical treatments
Key Trial Info
Start Date :
February 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04280913
Start Date
February 22 2020
End Date
March 31 2020
Last Update
March 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HuiZhou Municipal Central Hospital
Huizhou, Guangdong, China, 516001